We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Commentary · April 01, 2020

How Do We Plan HSCT and Cellular Therapy Given the COVID-19 Threat?

British Journal of Haematology


Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Haematology
How Do We Plan Hematopoietic Cell Transplant and Cellular Therapy With the Looming COVID-19 Threat?
Br. J. Haematol 2020 Mar 16;[EPub Ahead of Print], B Dholaria, BN Savani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading